Showing results (141-150 of 155) with videos related to
Sort By:
Pageof 16
Journal of the American Society of Nephrology : JASN|January 30, 2016
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney DiseaseChristina M Heyer, Jamie L Sundsbak, Kaleab Z Abebe, et al.Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.Kidney International|December 26, 2019
Detection and characterization of mosaicism in autosomal dominant polycystic kidney diseaseKatharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, et al.Nature Medicine|June 17, 2023
A meta-analysis of GFR slope as a surrogate endpoint for kidney failureLesley A Inker, Willem Collier, Tom Greene, et al.Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.Nephrology (Carlton, Vic.)|January 22, 2019
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique studyYeoungjee Cho, Benedicte Sautenet, Talia Gutman, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2020
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi SurveyYeoungjee Cho, Gopala Rangan, Charlotte Logeman, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney diseaseRonald D Perrone, Kaleab Z Abebe, Robert W Schrier, et al.Kidney International|December 30, 2011
Analysis of baseline parameters in the HALT polycystic kidney disease trialsVicente E Torres, Arlene B Chapman, Ronald D Perrone, et al.Pageof 16